Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
NEW YORK (
) hit a new 52-week low Wednesday as it is currently trading at $28.78, below its previous 52-week low of $28.83 with 420,056 shares traded as of 11:25 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.
Endo Health has a market cap of $3.41 billion and is part of the health care sector and drugs industry. Shares are down 15.6% year to date as of the close of trading on Tuesday.
Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally.
- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
TheStreet Ratings rates Endo Health as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. You can view the full
or get investment ideas from our
FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!
Free download now